Plagued by setbacks in the United States and Europe, IBM’s Watson Health business has clung to a comfortable — and potentially quite lucrative — fallback strategy: China.
Several hospitals there have begun using Watson to help treat cancer patients, and IBM formed strategic alliances with two Chinese firms to promote the use of the artificial intelligence software and get it into more facilities.
About the Authors Reprints
